期刊文献+

鲍曼不动杆菌环丙沙星耐药性接合转移的实验研究 被引量:2

Experimental Study on Conjugation Transfer of Ciprofloxacin Resistance in Acinetobacter baumanii
下载PDF
导出
摘要 目的:探讨质粒转移与鲍曼不动杆菌环丙沙星(CIP)耐药性的关系。方法:将鲍曼不动杆菌CIP耐药菌株(供体菌)与E.coli(C600SMRLac-)(受体菌)进行接合试验,采用琼脂稀释法测定供体菌及接合子的CIPMIC值。结果:16株CIP耐药性鲍曼不动杆菌,其中5株CIP耐药株与受体菌成功发生了接合,CIP耐药性接合转移的发生率为31.25%(5/16)。接合子的CIPMIC值比受体菌增加了30~500倍,其中1株接合子对CIP呈现低水平耐药。结论:部分鲍曼不动杆菌的CIP耐药性与质粒有关,且能够通过接合方式在细菌之间发生转移。 Objective: To investigate the relationship between plasmid transfer and ciprofloxacin resistance in A.baumanii. Methods: The conjugation experiments were carried out with ciprofloxacin-resistant A.baumanii as donor strains and E.coli (C600 SMR Lac ) as the recipient, and MICs for the donor, recipient, and transconjugant strains were measured by agar dilution. Results: Five strains of ciprofloxacin-resistant A. baumanii were conjugated with the recipient, and the incidence rate of conjugation transfer of ciprofloxacin resistance was 31.25%(5/16). Ciprofloxacin MICs for the transconjugant strains increased by 30 to 500 times than that of the recipient sWain, and one strain of the transconjugant was low-level ciprofloxacin resistance. Conclusion: In some isolates of A. baumanii, the ciprofioxacin resistance is realted to the plasmid, and can be transferred to other bacteria by conjugation.
出处 《抗感染药学》 2010年第1期39-41,共3页 Anti-infection Pharmacy
基金 广州市天河区卫生科技项目(编号:07KW006)
关键词 鲍曼不动杆菌 质粒 接合 环丙沙星 耐药 Acinetobacter baumanii plasmid conjugation ciprofloxacin resistance
  • 相关文献

参考文献8

二级参考文献31

  • 1糜祖煌,黄支密,秦玲.鲍氏不动杆菌耐药性和氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2004,14(9):968-971. 被引量:136
  • 2Nikado H. Outer mernberance barrier as a mechanism of antimicrobial resistance [ J ]. Antimicrob Agents Chemother,1989,33(11) : 1831.
  • 3Takiff HT, Cimino M, musso MC, et al. Efflux pump of the proton antiporter family confers low- level fluroquinolone resistance in Mycobacterium srnegmatis , [ J ]. Proc Natl Acad Sci USA, 1996,93 : 362.
  • 4Gull MJ, Brenwald NP, Wise R. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae [ J ]. Antimicrob Ageqtts Chemother, 1999,43 : 187.
  • 5Cecchetti V, Fravolini A, Palumbo M, et al. Potent 6 - de -sfluoro- 8 - methylquinolone as new lead compound in antibacterial chemotherapy [ J ]. J Med Chem, 1996,39 (25) :4952.
  • 6Renau TE, Leger R. Flamme EM, et al. Inhibitors of efflux pumps in Pseudornonas aeuruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin [ C]. Abstracts 39th ICAAC, 1999:326.
  • 7Markham PN. Inhibition of the emergence of ciproflixacin resistance in Streptococcus" preumoniae by the multidrug efflux inhibitor reserpine [J ]. Antimicrob Agents Chemther, 1999, 43:988.
  • 8Aeschlimann JR, Dresser LD, kaatz G W, et al. Effects of NorA inhibitors on in vitro antibacterial activities and pastantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus [ J ].Antimicrob Agents Chemother , 1999,43 : 335.
  • 9Markham PN, Neyfakh AA. Inhibition of the multidrug transporter Nora prevents emergerce of norflox aein resistance in Staphylococcus aureus [J ]. Antimicrob Agents Chemother ,1996,40 : 2673.
  • 10lopez Antunano FJ, Silva Sanchez J. Bacterial resistance to antibiotics in acute respiratory infections (ARIS) [J ]. Arch Med Res, 1997,28(2) : 195.

共引文献98

同被引文献20

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部